logo

Delmar Pharmaceuticals, Inc. (DMPI)



Trade DMPI now with
  Date
  Headline
6/24/2020 8:36:26 AM DelMar Pharma Gets $500K Loan From The National Brain Tumor Society And National Foundation For Cancer Research
6/22/2020 8:39:59 AM DelMar's VAL-083 Data Demonstrates Favorable Outcomes In Both Newly- Diagnosed And Recurrent GBM
6/10/2020 8:47:36 AM DelMar To Acquire Privately Held Adgero Biopharmaceuticals
6/4/2020 8:09:19 AM Global Coalition For Adaptive Research Selects DelMar Pharmaceuticals' VAL-083 To Participate In GBM AGILE Study
5/13/2020 8:03:54 AM DelMar Pharma Q3 Net Loss $1.96 Mln Or $0.17/shr Vs Loss $1.7 Mln Or $0.67/Shr Last Year
5/5/2020 8:20:13 AM DelMar Pharma Provides Enrollment Update In Phase 2 Clinical Trial Of VAL-083 For Adjuvant Treatment Of Brain Tumors
3/26/2020 8:01:38 AM DelMar Pharmas Receives Nasdaq Bid Price Extension Until Sept 21, 2020
3/26/2020 8:00:00 AM DelMar Pharmaceuticals Receives Nasdaq Bid Price Extension (Press Release)
3/4/2020 8:48:06 AM DelMar Says Exceeded 50% Enrollment In Adjuvant Arm Of Ongoing Phase 2 Clinical Study Of VAL-083
2/19/2020 8:08:59 AM DelMar Enrolls Final Patient In Phase 2 Trial Of VAL-083 For First-Line Treatment Of Brain Tumors
1/29/2020 8:15:25 AM DelMar Pharma Announces Peer-Reviewed Publication Of Interim Results Of Phase 2 Clinical Trial Of VAL-083
11/25/2019 9:58:33 AM DelMar : Interim Data Of VAL-083 Shows Favorable Outcomes In Both Recurrent And Newly-Diagnosed GBM
11/14/2019 8:06:01 AM DelMar Pharma Q1 Net Loss $1.6 Mln Or $0.21/shr Vs. Net Loss Of $2.0 Mln Or $0.88/shr Prior Year